US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Krystal Biotech Inc (KRYS)
Krystal Biotech Inc (KRYS) ニュース

KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:KRYS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	05 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/15	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Thoracic Society 2024 International Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/08	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at BofA Securities 2024 Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/02	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/26	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/22	20 : 00	GlobeNewswire Inc.	Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/04	20 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/29	11 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/28	21 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/27	03 : 35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	21 : 59	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	21 : 49	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	19 : 57	IH Market News	U.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices Retreat	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/20	21 : 00	GlobeNewswire Inc.	Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/13	21 : 00	GlobeNewswire Inc.	Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/08	21 : 00	GlobeNewswire Inc.	Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/01	21 : 00	GlobeNewswire Inc.	Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/25	07 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/23	01 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/04	21 : 00	GlobeNewswire Inc.	Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®	NASDAQ:KRYS	Krystal Biotech Inc
2023/12/19	21 : 00	GlobeNewswire Inc.	Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)	NASDAQ:KRYS	Krystal Biotech Inc
2023/11/27	21 : 00	GlobeNewswire Inc.	Krystal Biotech Announces EMA Validation of Marketing Authorization Application for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa	NASDAQ:KRYS	Krystal Biotech Inc

Showing the most relevant articles for your search:NASDAQ:KRYS

1 2 3 4 5 6 7 8 9 10 次へ >>

REGADO BIOSCIENCES INC

ABN Amro Bank NV 1.425% ...

Santaro Interactive Ente... (CE)

Vontobel Financial Produ...

Etf 3x L Jpy S�

PETRM237 Ex:20,88

Hearts and Minds Investm...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約